MICHAEL C PRIBULA

Allopathic & Osteopathic Physicians|Family Medicine MINERVA, OH NPI 1750910147

General Payments — all program years on this page

$2,030.38

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 79
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $321.51 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $321.5120

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2021 $460.4713
2022 $720.7127
2023 $527.6919
2024 $321.5120

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1097250189 Novo Nordisk Inc $13.66 07/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101273811 E.R. Squibb & Sons, L.L.C. $16.76 02/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101273825 E.R. Squibb & Sons, L.L.C. $19.99 05/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105312158 ABBVIE INC. $20.48 01/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105312161 ABBVIE INC. $17.73 08/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105312166 ABBVIE INC. $13.52 08/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105785598 AstraZeneca Pharmaceuticals LP $15.71 10/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115866846 GlaxoSmithKline, LLC. $14.57 03/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116036721 GlaxoSmithKline, LLC. $14.50 09/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116204440 GlaxoSmithKline, LLC. $15.71 04/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116240901 GlaxoSmithKline, LLC. $13.53 10/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118141288 Boehringer Ingelheim Pharmaceuticals, Inc. $14.15 11/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131398910 PFIZER INC. $15.69 04/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131884099 PFIZER INC. $17.93 08/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1132090629 PFIZER INC. $15.60 11/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141924308 Merck Sharp & Dohme LLC $13.27 11/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141979977 Merck Sharp & Dohme LLC $16.22 01/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144606216 Xeris Pharmaceuticals, Inc. $17.38 09/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151112024 Phathom Pharmaceuticals, Inc. $17.69 12/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151604827 Teva Pharmaceuticals USA, Inc. $17.42 12/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.